TipRanks
Go Ultimate55% OFF

Compare ImmunoCellular Therapeutics (IMUC) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
IMUCImmunoCellular Therapeutics$0.07$9.18M-4.78-59.78%―IMUC
XBIOXenetic Biosciences$2.05$4.80M-1.72-37.69%―IMUC vs XBIO
ADILAdial Pharmaceuticals$3.81$10.00M-0.30-57.27%Moderate BuyIMUC vs ADIL
INABIN8bio$0.90$8.89M-0.48-54.72%Moderate BuyIMUC vs INAB
BOLTBolt Biotherapeutics$6.59$12.69M-0.4115.01%NeutralIMUC vs BOLT

Performance Comparison

-100%-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
IMUCImmunoCellular Therapeutics0.07-0.11-59.78%
XBIOXenetic Biosciences2.05-1.07-34.29%
ADILAdial Pharmaceuticals3.81-4.81-55.83%
INABIN8bio0.90-0.98-52.07%
BOLTBolt Biotherapeutics6.591.0118.10%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts